Prelude Therapeutics (PRLD) Assets Growth (1y) (2020 - 2026)
Prelude Therapeutics (PRLD) Assets Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Prelude Therapeutics | 324.30 Mn | 179.71 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.30% |
| Dec 31, 2025 | -19.49% |
| Sep 30, 2025 | -51.95% |
| Jun 30, 2025 | -48.76% |
| Mar 31, 2025 | -42.83% |
| Dec 31, 2024 | -36.79% |
| Sep 30, 2024 | -23.71% |
| Jun 30, 2024 | -20.07% |
| Mar 31, 2024 | 24.60% |
| Dec 31, 2023 | 25.93% |
| Sep 30, 2023 | 6.68% |
| Jun 30, 2023 | 8.32% |
| Mar 31, 2023 | -29.34% |
| Dec 31, 2022 | -27.73% |
| Sep 30, 2022 | -26.84% |
| Jun 30, 2022 | -25.90% |
| Mar 31, 2022 | -24.11% |
| Dec 31, 2021 | 36.45% |
| Sep 30, 2021 | 38.19% |
| Dec 31, 2020 | 922.31% |